Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mason W Freeman

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|October 25, 2008
Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic miceJennifer J Manning-Tobin, Kathryn J Moore, Tracie A Seimon, et al.
Nature Medicine|March 23, 2004
Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathwaysHarry Björkbacka, Vidya V Kunjathoor, Kathryn J Moore, et al.
Diabetes, Obesity & Metabolism|December 27, 2023
Meta-analysis of risk of major adverse cardiovascular events in adults with type 2 diabetes treated with bexagliflozinJohn J V McMurray, Scott D Solomon, J Paul Lock, et al.
Biochemistry|May 20, 2008
SPTLC1 binds ABCA1 to negatively regulate trafficking and cholesterol efflux activity of the transporterNorimasa Tamehiro, Suiping Zhou, Keiichiro Okuhira, et al.
Thrombosis and Haemostasis|November 26, 2011
The Creating an Optimal Warfarin Nomogram (CROWN) StudyTodd S Perlstein, Samuel Z Goldhaber, Kerrie Nelson, et al.
Journal of Lipid Research|December 5, 2006
ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerolMichael L Fitzgerald, Ramnik Xavier, Kathleen J Haley, et al.
The New England Journal of Medicine|July 14, 2025
Phase 2a Study of Baxdrostat in Primary AldosteronismAdina F Turcu, Mason W Freeman, Irina Bancos, et al.
Open Forum Infectious Diseases|March 4, 2015
High-density lipoprotein-mediated cholesterol efflux capacity is improved by treatment with antiretroviral therapy in acute human immunodeficiency virus infectionJanet Lo, Eric S Rosenberg, Michael L Fitzgerald, et al.
Circulation|July 27, 2005
Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitmentEric A Heller, Emerson Liu, Andrew M Tager, et al.
Nature Reviews. Drug Discovery|August 5, 2017
NIH Centers for Accelerated Innovations Program: principles, practices, successes and challengesElliott M Antman, Paul E Di Corleto, Mason W Freeman, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Arteriosclerosis, Thrombosis, and Vascular Biology|October 25, 2008
Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic miceJennifer J Manning-Tobin, Kathryn J Moore, Tracie A Seimon, et al.
Nature Medicine|March 23, 2004
Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathwaysHarry Björkbacka, Vidya V Kunjathoor, Kathryn J Moore, et al.
Diabetes, Obesity & Metabolism|December 27, 2023
Meta-analysis of risk of major adverse cardiovascular events in adults with type 2 diabetes treated with bexagliflozinJohn J V McMurray, Scott D Solomon, J Paul Lock, et al.
Biochemistry|May 20, 2008
SPTLC1 binds ABCA1 to negatively regulate trafficking and cholesterol efflux activity of the transporterNorimasa Tamehiro, Suiping Zhou, Keiichiro Okuhira, et al.
Thrombosis and Haemostasis|November 26, 2011
The Creating an Optimal Warfarin Nomogram (CROWN) StudyTodd S Perlstein, Samuel Z Goldhaber, Kerrie Nelson, et al.
Journal of Lipid Research|December 5, 2006
ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerolMichael L Fitzgerald, Ramnik Xavier, Kathleen J Haley, et al.
The New England Journal of Medicine|July 14, 2025
Phase 2a Study of Baxdrostat in Primary AldosteronismAdina F Turcu, Mason W Freeman, Irina Bancos, et al.
Open Forum Infectious Diseases|March 4, 2015
High-density lipoprotein-mediated cholesterol efflux capacity is improved by treatment with antiretroviral therapy in acute human immunodeficiency virus infectionJanet Lo, Eric S Rosenberg, Michael L Fitzgerald, et al.
Circulation|July 27, 2005
Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitmentEric A Heller, Emerson Liu, Andrew M Tager, et al.
Nature Reviews. Drug Discovery|August 5, 2017
NIH Centers for Accelerated Innovations Program: principles, practices, successes and challengesElliott M Antman, Paul E Di Corleto, Mason W Freeman, et al.
Pageof 7